新規ドラッグデリバリーシステム（NDDS）の世界市場

新規ドラッグデリバリーシステム（NDDS）の世界市場は2030年までに655億米ドルに達する見込み

2023年に163億米ドルと推定される新規ドラッグデリバリーシステム（NDDS）の世界市場は、分析期間2023-2030年に21.9%のCAGRで成長し、2030年には655億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるNDDS用ナノ粒子は、CAGR 21.4%を記録し、分析期間終了までに519億米ドルに達すると予測されます。NDDS用塞栓用粒子セグメントの成長率は、分析期間中CAGR 24.1%と推定されます。

米国市場は57億米ドルと推定、中国はCAGR26.6%で成長予測

米国の新規ドラッグデリバリーシステム（NDDS）市場は2023年に57億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに74億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは26.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.9%と19.9%と予測されています。欧州では、ドイツがCAGR 20.3%で成長すると予測されています。

世界の新規ドラッグデリバリーシステム（NDDS）市場- 主要動向と促進要因まとめ

新規ドラッグデリバリーシステム（NDDS）とは、有効性、安全性、治療レジメンに対する患者のコンプライアンスを高める方法で患者に薬剤を送達する革新的な方法を指します。これらのシステムは、体内の特定の部位に直接ドラッグを送達することを目標とし、ドラッグの放出速度を制御し、副作用を最小限に抑えながら治療指数を最大化するように設計されています。NDDSには、リポソーム、ナノ粒子、マイクロニードル、薬剤溶出ステントなど、さまざまなデリバリー・プラットフォームが含まれます。これらの技術は薬剤の制御された徐放を可能にし、投与回数を減らして患者の転帰を改善する可能性があります。この分野は、慢性疾患やがんの治療、ワクチンの送達において特に重要です。

研究者と製薬会社が従来のドラッグデリバリー法の限界を克服することを目指しているため、NDDSの開発は成長を続けています。従来の薬物療法における重要な課題のひとつは、副作用を引き起こすことなく薬剤の最適な治療レベルを達成することであり、NDDSは高度な製剤技術と工学技術によってこの課題を簡素化することを目指しています。例えば、ナノ粒子のEPR（Enhanced permeability and retention）効果により、腫瘍細胞に的を絞ったドラッグデリバリーが可能になり、健康な組織への影響を最小限に抑え、がん治療における副作用を軽減することができます。さらに、NDDSに生分解性材料を応用することで、より安全で効果的なドラッグデリバリー・メカニズムが促進され、持続可能な医療行為に対する需要の高まりと一致します。さらに、センサーを搭載したスマートピルのようなドラッグデリバリーシステムにデジタル技術を統合することで、薬剤放出や患者の服薬遵守に関するリアルタイムのデータが得られ、正確な投与量を必要とする治療には不可欠となります。

新規ドラッグデリバリーシステム市場の成長は、材料科学やバイオテクノロジーの技術的進歩、慢性疾患の蔓延、より良いオーダーメイドのヘルスケアソリューションを求める情報通の消費者層など、いくつかの要因によって牽引されています。ナノテクノロジーと分子生物学の進歩は、より効率的なドラッグデリバリーシステムの開発に特に役立っています。これらの技術革新により、薬物を生体適合性のある材料に封入することが可能になり、身体の自然なバリアを迂回して、疾患部位に直接、制御された速度で薬物を放出することができるようになった。さらに、糖尿病や心臓病といった慢性疾患の罹患率が上昇していることも、より効率的で利便性の高いドラッグデリバリー方法への需要を煽り、NDDSの研究開発へのさらなる投資を促しています。最後に、患者の健康管理に関する意思決定への関与が高まるにつれ、効果的なだけでなく非侵襲的で利便性の高いドラッグデリバリーシステムに対する需要が高まっており、市場の持続的成長と革新に向けた舵取りが行われています。

調査対象企業の例（全238件）

• Alexza Pharmaceuticals
• Ademtech SA
• Acerus Pharmaceuticals Corporation
• Adocia
• Aerogen
• Aktivax, Inc.
• 2C Tech
• Acuitas Therapeutics
• Applied Nanoparticles
• Apogee Technology, Inc.
• 20Med Therapeutics
• AnTolRx Inc.
• Adipo Therapeutic
• AcelRx Pharmaceuticals
• Advanced NanoTherapies Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

Global Novel Drug Delivery Systems (NDDS) Market to Reach US$65.5 Billion by 2030

The global market for Novel Drug Delivery Systems (NDDS) estimated at US$16.3 Billion in the year 2023, is expected to reach US$65.5 Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2023-2030. Nanoparticles for NDDS, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by the end of the analysis period. Growth in the Embolization Particles for NDDS segment is estimated at 24.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.7 Billion While China is Forecast to Grow at 26.6% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$5.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.4 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.9% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 20.3% CAGR.

Global Novel Drug Delivery Systems (NDDS) Market - Key Trends and Drivers Summarized

Novel Drug Delivery Systems (NDDS) refer to innovative methods for delivering medication to patients in a manner that increases the efficacy, safety, and patient compliance with the treatment regimen. These systems are designed to target the delivery of drugs directly to a specific site in the body, control the rate of drug release, and maximize the therapeutic index while minimizing side effects. NDDS encompasses a variety of delivery platforms including liposomes, nanoparticles, microneedles, and drug-eluting stents, among others. These technologies enable controlled and sustained release of medications, potentially reducing dosage frequency and improving patient outcomes. This field is particularly significant in the treatment of chronic diseases, cancer, and for the delivery of vaccines.

The development of NDDS continues to grow as researchers and pharmaceutical companies aim to overcome the limitations of conventional drug delivery methods. One of the key challenges in traditional pharmacotherapy is achieving optimal therapeutic levels of a drug without causing adverse effects, a task that NDDS aims to simplify through advanced formulation and engineering techniques. Enhanced permeability and retention (EPR) effect of nanoparticles, for example, allows for targeted drug delivery to tumor cells, minimizing the impact on healthy tissues and reducing side effects in cancer treatments. Moreover, the application of biodegradable materials in NDDS promotes safer and more effective drug delivery mechanisms, aligning with the growing demand for sustainable medical practices. Additionally, the integration of digital technology into drug delivery systems, such as smart pills equipped with sensors, provides real-time data on drug release and patient adherence, which can be critical for treatments requiring precise dosages.

The growth in the Novel Drug Delivery Systems market is driven by several factors including technological advancements in material science and biotechnology, increasing prevalence of chronic diseases, and a more informed consumer base demanding better and more tailored healthcare solutions. Advancements in nanotechnology and molecular biology have been particularly instrumental in developing more efficient drug delivery systems. These innovations allow drugs to be encapsulated in biocompatible materials that can bypass the body's natural barriers and release drugs at a controlled rate directly at the disease site. Additionally, the rising incidence of chronic conditions such as diabetes and heart disease fuels the demand for more efficient and convenient drug delivery methods, encouraging further investment in NDDS research and development. Lastly, as patients become more engaged in their health care decisions, there is a growing demand for drug delivery systems that are not only effective but also non-invasive and convenient, steering the market towards sustained growth and innovation.

Select Competitors (Total 238 Featured) -

• Alexza Pharmaceuticals
• Ademtech SA
• Acerus Pharmaceuticals Corporation
• Adocia
• Aerogen
• Aktivax, Inc.
• 2C Tech
• Acuitas Therapeutics
• Applied Nanoparticles
• Apogee Technology, Inc.
• 20Med Therapeutics
• AnTolRx Inc.
• Adipo Therapeutic
• AcelRx Pharmaceuticals
• Advanced NanoTherapies Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Novel Drug Delivery Systems (NDDS) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Novel Drug Delivery System (NDDS): A Prelude
  • Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
  • Patient Compliance: A Key Reason Garnering Interest in NDD
  • Regulatory Process for Novel Drug Delivery Systems
  • A Look into Current Areas of Research in Drug Delivery
  • Market Outlook
  • Nanotechnology-Enabled Drug Delivery: Primary Challenges
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Nanotechnology Bolsters Demand for NDDS
  • Prospects Remain Encouraging
  • Microfluidics Mediated NDDS Set to Make Gains
  • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
  • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
  • List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
  • Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
  • Dendrimers as Ideal Drug Delivery Agents
  • List of Commercially Available Dendrimeric Products by Application Area
  • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
  • Oral Thin Films Enhance NDDS Domain
  • Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
  • Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
  • Global Breakdown of Total Number of Cancer Cases by Type: 2020
  • Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
  • Uptrend in Gene Therapy Market Augurs Well for Market Growth
  • Global Gene Therapy Market in US$ Million: 2020, 20223 and 2024
  • Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
  • Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
  • Global Annual Medical Cost of CVD in US$ Billion (2020-2030)
  • NDD for Antimicrobial Drugs
  • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
  • Nanotechnology Opens New Avenues in Antiretroviral Therapy
  • Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
  • Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
  • Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems: Number of People Living with AIDs (in Thousands) by Region
  • Novel Drug Delivery Systems for CNS Therapeutics
  • Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
  • Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases' Treatment
  • Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
  • Exciting Immunology Developments Involving Graphene-based Nanomaterials
  • Nanotechnology-Based Strategies for siRNA Grows in Popularity
  • Nanoemulsions Begin to Make a Mark
  • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
  • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
  • Recent Advancements in Polymeric Drug Delivery Systems
  • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
  • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
  • SLNs in Pulmonary Delivery of Drugs
  • Other Nanocarriers in Pulmonary Delivery
  • Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
  • Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
  • Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 3: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 4: World 7-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World 7-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 7: World Novel Drug Delivery Systems (NDDS) Market Analysis of Annual Sales in US$ Million for Years 2020 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 8: USA Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 9: USA 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• CANADA
  • TABLE 10: Canada Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 11: Canada 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• JAPAN
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 12: Japan Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 13: Japan 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• CHINA
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 14: China Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: China 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• EUROPE
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 16: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 18: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• FRANCE
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 20: France Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: France 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• GERMANY
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 22: Germany Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Germany 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• ITALY
  • TABLE 24: Italy Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Italy 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• UNITED KINGDOM
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 26: UK Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: UK 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Rest of Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• ASIA-PACIFIC
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Asia-Pacific 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 32: Rest of World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Rest of World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030

IV. COMPETITION